122 related articles for article (PubMed ID: 7686410)
1. Synthesis, biological activity, and conformational analysis of [pGlu6,N-MePhe8,Aib9] substance P (6-11): a selective agonist for the NK-3 receptor.
Tallon M; Ron D; Halle D; Amodeo P; Saviano G; Temussi PA; Selinger Z; Naider F; Chorev M
Biopolymers; 1993 Jun; 33(6):915-26. PubMed ID: 7686410
[TBL] [Abstract][Full Text] [Related]
2. 1H-NMR studies of receptor-selective substance P analogues reveal distinct predominant conformations in DMSO-d6.
Levian-Teitelbaum D; Kolodny N; Chorev M; Selinger Z; Gilon C
Biopolymers; 1989 Jan; 28(1):51-64. PubMed ID: 2470438
[TBL] [Abstract][Full Text] [Related]
3. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
6. Desensitization with a selective agonist discriminates between multiple tachykinin receptors.
Laufer R; Gilon C; Chorev M; Selinger Z
J Pharmacol Exp Ther; 1988 May; 245(2):639-43. PubMed ID: 2835478
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
8. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity.
Haro I; Busquets MA; Torres JL; Valencia G; Garcia-Anton JM; Reig F
J Pharm Sci; 1990 Jan; 79(1):74-6. PubMed ID: 1690289
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
[TBL] [Abstract][Full Text] [Related]
10. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
11. Conformational solution studies of neuropeptide gamma using CD and NMR spectroscopy.
Rodziewicz-Motowidło S; Brzozowskl K; Legowska A; Liwo A; Silbering J; Smoluch M; Rolka K
J Pept Sci; 2002 May; 8(5):211-26. PubMed ID: 12043996
[TBL] [Abstract][Full Text] [Related]
12. Conformational analysis of receptor selective tachykinin analogs: senktide and septide.
Sumner SC; Jiang SP; Jernigan RL; Ferretti JA
J Biomol Struct Dyn; 1992 Dec; 10(3):429-39. PubMed ID: 1283515
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis of cyclic and non-cyclic tachykinin partial sequences. 2. Synthesis of the homocyclic substance P(6-11) hexapeptide].
Neubert K; Hartrodt B; Mehlis B; Rüger M; Bergmann J; Lindau J; Jakubke HD; Barth A
Pharmazie; 1985 Aug; 40(8):532-5. PubMed ID: 2417264
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
18. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.
Stavropoulos G; Karagiannis K; Cordopatis P; Halle D; Gilon C; Bar-Akiva G; Selinger Z; Chorev M
Int J Pept Protein Res; 1991 Mar; 37(3):180-4. PubMed ID: 1714423
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group.
Kruszyński M; Kupryszewski G; Misterek K; Gumułka S
Pol J Pharmacol Pharm; 1990; 42(5):483-90. PubMed ID: 1711685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
